Health campaigners and medical charities are calling for a wider rollout of meningitis vaccines across the UK after the death of an Oxfordshire teenager from meningococcal disease renewed concerns over protection for young people against the potentially deadly infection.
The latest case has intensified pressure on the British government to expand access to the Meningitis B vaccine, commonly known as MenB, which is currently not routinely offered to teenagers and young adults through the NHS vaccination programme.
The renewed debate follows the death of Lewis Waters, a sixth-form student at The Henley College, who died earlier this week after contracting meningitis.
Two additional students — one from Reading Blue Coat School and another from Highdown Secondary School and Sixth Form Centre — are also being treated for meningitis, according to health authorities.
The cases have raised fears about the continued spread of meningococcal disease among teenagers and young adults, groups considered among the most vulnerable to infection.
Charity Calls for Wider MenB Vaccine Access
Meningitis Now has urged ministers to expand routine access to the MenB vaccine for older children, teenagers and university-age young adults.
Dr Tom Nutt, the charity’s chief executive, said the current vaccination policy leaves many young people exposed to preventable risks.
“Young lives are really precious and we should do everything we can to protect them,” he said.
Nutt criticised the fact that MenB vaccination is not routinely available to teenagers through the NHS immunisation programme.
He argued that the main reason for limiting access is cost rather than medical effectiveness.
“The argument against the introduction of the MenB vaccination for teenagers and young adults is actually around cost effectiveness,” he said.
“The lives of teenagers and young adults are too precious and it is tragic to see yet another death.”
MenB Vaccine Currently Limited in UK
The MenB vaccine is currently offered in the UK mainly to babies as part of the routine childhood vaccination programme.
Health experts say the vaccine has dramatically reduced cases among infants since its introduction.
Dr Nutt noted there has been “about 75% less disease in the under-ones than there was before the vaccine was introduced.”
He added that the vaccine is widely recognised as both safe and effective, although relatively expensive.
While teenagers are routinely offered the MenACWY vaccine through schools, that vaccine does not protect against MenB strains.
The MenACWY jab covers meningococcal groups A, C, W and Y, but MenB remains one of the leading causes of bacterial meningitis among young people in the UK.
The UK Health Security Agency confirmed that one of the recent cases had been identified as MenB, while tests on the other two students are continuing.
Health Officials Monitor Linked Cases
The UKHSA said investigators identified a social network connecting Lewis Waters and the two other affected students.
As a precaution, antibiotics are being offered to close contacts linked to all three cases in an effort to prevent further spread.
Public health officials stressed that the risk to the wider population remains low.
However, the latest infections are part of a broader rise in concern over meningitis outbreaks involving young people across England.
Two months ago, two people died from MenB infections linked to a nightclub in Canterbury, Kent.
Earlier this year, three additional young people contracted meningitis in Dorset.
Health authorities say meningococcal disease remains relatively rare but can develop rapidly and become life-threatening within hours.
Symptoms Can Develop Suddenly
Doctors are urging parents, students and schools to remain alert to meningitis symptoms, which can appear suddenly and worsen quickly.
Symptoms can include:
* High fever
* Severe headache
* Stiff neck
* Vomiting
* Muscle and joint pain
* Sensitivity to light
* Cold hands and feet
* Extreme tiredness
* Seizures
* Confusion or delirium
* A rash that does not fade when pressed with a glass
Medical experts warn that not all symptoms appear immediately, making early diagnosis difficult in some cases.
Meningitis affects the protective membranes surrounding the brain and spinal cord and can be caused by bacterial or viral infections.
Bacterial meningitis, including meningococcal disease, is particularly dangerous because it can lead to blood poisoning, organ failure, brain damage or death.
Pressure Builds on Government Review
The Department of Health and Social Care confirmed that the Joint Committee on Vaccination and Immunisation is reviewing eligibility for routine MenB vaccination.
The review comes after growing calls from health campaigners, bereaved families and medical organisations for broader protection against meningococcal disease.
A government spokesperson said ministers requested updated recommendations from the JCVI following the Canterbury outbreak and emerging evidence regarding MenB transmission among young people.
“The JCVI is carrying out a review of eligibility for routine MenB vaccination and will provide a further update and advice to the department in due course,” the spokesperson said.
Officials also defended Britain’s vaccination programme, describing it as “world-leading.”
Universities and Teenagers Seen as Higher-Risk Groups
Health specialists say teenagers and university students face increased risk because meningococcal bacteria spread more easily through close social contact.
Living in shared accommodation, attending crowded events and frequent social interaction can increase transmission risks.
This is why vaccination campaigns targeting students have become a major public health issue in several countries.
Campaigners argue that wider MenB vaccination could reduce hospitalisations, long-term disabilities and deaths among teenagers and young adults.
Dr Nutt said policymakers should consider not only healthcare costs but also the wider social and economic benefits of preventing serious illness.
“Health is an asset that we really must protect,” he said.
Growing Concern Over Meningitis Awareness
Despite ongoing vaccination programmes, health charities say public awareness of meningitis symptoms and vaccine limitations remains inconsistent.
There are approximately 300 to 400 confirmed cases of meningococcal disease diagnosed annually in England.
The illness is most common among babies, young children, teenagers and young adults.
Medical experts stress that rapid treatment with antibiotics is critical for survival.
The UKHSA has encouraged young people to ensure they are fully vaccinated and up to date with available meningitis vaccines, including MenACWY.
However, campaigners say the recent deaths and infections highlight a major gap in protection against MenB strains.
With pressure now mounting on ministers and health advisers, the government’s review of MenB vaccine eligibility is likely to face growing public scrutiny in the months ahead.